Static vs. Dynamic Progressive Splinting for Persistent Wrist Stiffness After DRF
This randomized controlled trial will compare the effectiveness of static progressive splinting versus dynamic splinting for treating persistent wrist stiffness in adults ≥18 years old at least 8 weeks post distal radius fracture (DRF) injury. Both splinting modalities are provided as an adjunct to one weekly supervise
| Condition(s) | Distal Radius Fractures |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This randomized controlled trial will compare the effectiveness of static progressive splinting versus dynamic splinting for treating persistent wrist stiffness in adults ≥18 years old at least 8 weeks post distal radius fracture (DRF) injury. Both splinting modalities are provided as an adjunct to one weekly supervised therapy session over a 6-week period. The primary outcomes are wrist active and passive range of motion (AROM/PROM) measured using goniometry, with secondary outcomes including patient-reported wrist function (PRWE), overall satisfaction, and adverse events. |
| Who can participate | Inclusion Criteria: Adults aged 18 years or older. At least 8 weeks post distal radius fracture (operative or nonoperative) who have completed standard rehabilitation. Demonstrated persistent wrist stiffness with ≤50% of contralateral wrist extension or flexion. Capable of providing written informed consent and complying with study procedures Exclusion Criteria: Presence of complex regional pain syndrome (CRPS) or active fracture healing issues. History of significant wrist pathology unrelated to the DRF. Uncontrolled medical conditions that would interfere with splint application or therapy. Known skin conditions or allergies that preclude orthosis use. Inability or unwillingness to adhere to the intervention protocol or follow-up schedule. Pregnant or breastfeeding individuals. |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Lead sponsor | Al Hayah University In Cairo |
| Locations | Cairo, Egypt |
| Start date | 2025-04-17 |
| NCT ID | NCT06913933 |
| Official listing | https://clinicaltrials.gov/study/NCT06913933 |